Actively Recruiting
Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
Led by GenieBiome Limited · Updated on 2024-09-19
40
Participants Needed
2
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to explore the efficacy and safety of a synbiotic formula (BLHK03) in alleviating chemotherapy-induced alopecia (CIA) in breast cancer patients and the compositional and functional changes in the gut microbiome of breast cancer patients undergoing chemotherapy and treatment with BLHK03.
CONDITIONS
Official Title
Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged between 18 and 60 years
- Newly diagnosed with stage I, II, or III breast cancer
- Planned chemotherapy including an anthracycline or taxane to be completed within 6 months
- Mentally capable to participate in the study and provide informed consent
You will not qualify if you...
- Pre-existing female-pattern baldness resembling picture I-3 or higher on the Savin scale at baseline
- History of hair transplantation, psoriasis, or severe scalp infection
- Undergoing or planning to receive scalp cooling
- Plan for immunotherapy
- Known pregnancy or lactating
- Severe cardiac, hepatic, renal, pulmonary, haematic lesions, or other life-threatening conditions
- Use of antibiotics, probiotics, or prebiotics one month prior to enrolment
- Use of alternative or complementary treatments that may affect gut microbiome analysis
- History of allergy to probiotics or lactose
- History of chemotherapy for other conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
GenieBiome Limited
Hong Kong, Hong Kong
Not Yet Recruiting
2
Heal Medical
Hong Kong, Hong Kong
Actively Recruiting
Research Team
E
Emily Chiu, BSc
CONTACT
P
Pui Kuan Cheong, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here